|
| 37861398 | Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy. | Clin Cancer Res | 2024 |
| 37861398 | Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy. | Clin Cancer Res | 2024 |
| 36346321 | Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data. | Sci Transl Med | 2023 |
| 36346321 | Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data. | Sci Transl Med | 2023 |
| 37747367 | Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma. | Oncotarget | 2023 |
| 37729428 | Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma. | Cancer Res | 2023 |
| 37563418 | Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma. | Commun Biol | 2023 |
| 37474523 | Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. | Nat Commun | 2023 |
| 37207151 | Educational level-dependent melanoma awareness in a high-risk population in Switzerland. | Front Oncol | 2023 |
| 37453242 | Diagnostic performance of augmented intelligence with 2DÂ and 3DÂ total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? | Eur J Cancer | 2023 |
| 37119050 | Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitors. | Cancer Med | 2023 |
| 37513847 | Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis. | Pharmaceuticals (Basel) | 2023 |
| 36785973 | The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. | J Eur Acad Dermatol Venereol | 2023 |
| 37747367 | Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma. | Oncotarget | 2023 |
| 37513847 | Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis. | Pharmaceuticals (Basel) | 2023 |
| 37729428 | Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma. | Cancer Res | 2023 |
| 37563418 | Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma. | Commun Biol | 2023 |
| 37119050 | Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitors. | Cancer Med | 2023 |
| 37453242 | Diagnostic performance of augmented intelligence with 2DÂ and 3DÂ total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? | Eur J Cancer | 2023 |
| 37207151 | Educational level-dependent melanoma awareness in a high-risk population in Switzerland. | Front Oncol | 2023 |
| 37474523 | Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. | Nat Commun | 2023 |
| 36785973 | The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. | J Eur Acad Dermatol Venereol | 2023 |
| 35139377 | Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells. | Cell Rep | 2022 |
| 35954491 | Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception. | Cancers (Basel) | 2022 |
| 35693944 | Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation. | Front Cell Dev Biol | 2022 |
| 36077695 | The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. | Cancers (Basel) | 2022 |
| 35993275 | The A to I editing landscape in melanoma and its relation to clinical outcome. | RNA Biol | 2022 |
| 36412914 | Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5. | Noncoding RNA | 2022 |
| 35850206 | Defining the Molecular Landscape of Cancer-Associated Stroma in Cutaneous Squamous Cell Carcinoma. | J Invest Dermatol | 2022 |
| 36580495 | Impact of Covid-19 on the management of patients with metastatic melanoma. | Oncotarget | 2022 |
| 35145509 | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer. | Front Immunol | 2022 |
| 35139377 | Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells. | Cell Rep | 2022 |
| 35693944 | Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation. | Front Cell Dev Biol | 2022 |
| 35850206 | Defining the Molecular Landscape of Cancer-Associated Stroma in Cutaneous Squamous Cell Carcinoma. | J Invest Dermatol | 2022 |
| 36580495 | Impact of Covid-19 on the management of patients with metastatic melanoma. | Oncotarget | 2022 |
| 36412914 | Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5. | Noncoding RNA | 2022 |
| 35993275 | The A to I editing landscape in melanoma and its relation to clinical outcome. | RNA Biol | 2022 |
| 35954491 | Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception. | Cancers (Basel) | 2022 |
| 36077695 | The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. | Cancers (Basel) | 2022 |
| 35145509 | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer. | Front Immunol | 2022 |
| 32910840 | NRAS<sup>Q61K</sup> melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells. | Pigment Cell Melanoma Res | 2021 |
| 33962053 | A Comparative Study of Real-Time RT-PCR-Based SARS-CoV-2 Detection Methods and Its Application to Human-Derived and Surface Swabbed Material. | J Mol Diagn | 2021 |
| 34208218 | Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis. | Cancers (Basel) | 2021 |
| 33775845 | Prolonged Unfrozen Storage and Repeated Freeze-Thawing of SARS-CoV-2 Patient Samples Have Minor Effects on SARS-CoV-2 Detectability by RT-PCR. | J Mol Diagn | 2021 |
| 33664264 | Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. | Nat Commun | 2021 |
| 33445472 | Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. | Noncoding RNA | 2021 |
| 33823361 | Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response. | Eur J Cancer | 2021 |
| 32910840 | NRAS<sup>Q61K</sup> melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells. | Pigment Cell Melanoma Res | 2021 |
| 34454317 | Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. | Eur J Cancer | 2021 |
| 34645608 | Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression. | Cancer Res | 2021 |